CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
E3508: Randomized trial of carboplatin (C), paclitaxel (P), bevacizumab (B) with or without cixutumumab (Cx) in patients (pts) with advanced non-squamous, non-small cell lung cancer (NSCLC).
Author
Athanassios Argiris
James Stevenson
+10Â more
Joan H. Schiller
Joel N. Saltzman
Ju-Whei Lee
Matthew Gerard Sulecki
Nicholas W. Choong
Richard M. Hansen
Suresh S. Ramalingam
Tracey L. Evans
Vladimir Hugec
Wei Song
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Phase I/II study of rilotumumab (R) and erlotinib (E) in previously treated patients (pts) with metastatic NSCLC.
Author
Ahmad A. Tarhini
Alexis Megaludis
+17Â more
Andrew D. Laman
Daniel P. Petro
David Friedland
Dhaval R. Mehta
Grace R. Tarabay
Imran Rafique
Kevin M. Kane
Kiran K. Rajasenan
Lijun Dai
Liza Cosca Villaruz
Mark A. Socinski
Mark S. Georgiadis
Matthew Gerard Sulecki
Phu Tran
Sajid M. Peracha
Timothy Francis Burns
William E. Gooding
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref